Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,683 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA)

NCT06606847

Conditions
Bronchial Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Research Site Kazan', Russia
  • Research Site Moscow, Russia
  • Research Site Moscow, Russia
  • Research Site Moscow, Russia
View Trial Details
Active, Not Recruiting

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

NCT05462717

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +60 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • UC Irvine Cancer Center Orange, California, United States
  • UC Davis Cancer Center Sacramento, California, United States
  • UCSF San Francisco, California, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)

NCT04526691

Conditions
Advanced or Metastatic NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • Johns Hopkins Kimmel Cancer Center Washington D.C., District of Columbia, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer

NCT03807778

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Fujita Health University Hospital Toyoake, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • Kurume University Hospital Kurume, Fukuoka, Japan
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)

NCT06946797

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Local Institution - 0032 Anchorage, Alaska, United States
  • Local Institution - 0062 Los Angeles, California, United States
  • Local Institution - 0063 Boise, Idaho, United States
  • Local Institution - 0052 Boise, Idaho, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

THIO Sequenced With Cemiplimab in Advanced NSCLC

NCT05208944

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +14 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • Summit Health Florham Park, New Jersey, United States
  • Sunshine Coast Haematology and Oncology Clinic Buderim, Queensland, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View all 35 locations
View Trial Details
Active, Not Recruiting

National Cancer Institute "Cancer Moonshot Biobank"

NCT04314401

Conditions
Acute Myeloid Leukemia, Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, +98 more
Locations
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland Saraland, Alabama, United States
View all 150 locations
View Trial Details

Related conditions